Velocardiofacial syndrome (VCFS) is a genetic disability syndrome that is c
aused, in most cases, by a de-novo 3 Mb microdeletion at chromosome region
22q11.2. The behavioral phenotype includes characteristic developmental, co
gnitive, and linguistic deficits, and psychiatric disorders, including chil
dhood abnormalities of attention, mood, and anxiety. Recently, it was estab
lished that approximately 30% of people with VCFS develop schizophrenia, es
tablishing VCFS as the first known genetic cause of schizophrenia. There ha
s been recent progress in describing the molecular biology of the deletion
site, characterizing the behavioral phenotype, and in defining the structur
al brain abnormalities in VCFS. However, numerous knowledge gaps remain in
tracing the pathways from gene expression to brain structure, and to cognit
ive and psychiatric symptoms. Curr Opin Psychiatry 13:485-490; (C) 2000 Lip
pincott Williams & Wilkins.